Human Immunoglobulin (pH4) for Intravenous Injection, Freeze-dried(Boya Bio-Pharmaceutical)

冻干静注人免疫球蛋白(pH4)（博雅生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Immunoglobulin (pH4) for Intravenous Injection, Freeze-dried(Boya Bio-Pharmaceutical)
Drug Alias Name博欣
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsX chain low immunoglobulinAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[4] 
Global Approved IndicationsX chain low immunoglobulinAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[4] 
Approved Indications in ChinaX chain low immunoglobulinAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBoya Bio-Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoya Bio-Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsX chain low immunoglobulinAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksN/A